TipRanks
Nissan Medical Industries Ltd. (IL:NISA)
TASE:NISA
Israel Market

Nissan (NISA) Ratios

2 Followers

Nissan Ratios

IL:NISA's free cash flow for Q2 2026 was ₪0.22. For the 2026 fiscal year, IL:NISA's free cash flow was decreased by ₪ and operating cash flow was ₪0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
0.98 0.99 1.11 1.16 1.17
Quick Ratio
0.47 0.47 0.43 0.64 0.69
Cash Ratio
0.06 0.08 0.06 0.11 0.09
Solvency Ratio
0.10 0.09 0.11 0.10 -0.02
Operating Cash Flow Ratio
0.25 0.23 0.11 0.48 0.05
Short-Term Operating Cash Flow Coverage
0.42 0.36 0.18 0.92 0.10
Net Current Asset Value
₪ -88.27M₪ -92.98M₪ -76.49M₪ -95.25M₪ -147.22M
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.31 0.29 0.28 0.34
Debt-to-Equity Ratio
0.96 0.98 0.88 0.87 1.17
Debt-to-Capital Ratio
0.49 0.49 0.47 0.46 0.54
Long-Term Debt-to-Capital Ratio
0.16 0.15 0.17 0.23 0.36
Financial Leverage Ratio
3.23 3.19 3.07 3.09 3.42
Debt Service Coverage Ratio
0.32 0.29 0.35 0.52 -0.07
Interest Coverage Ratio
1.84 1.27 1.70 2.95 -1.89
Debt to Market Cap
1.96 2.09 3.65 1.87 3.02
Interest Debt Per Share
21.30 22.77 55.08 24.17 29.01
Net Debt to EBITDA
3.32 3.69 3.21 2.16 -27.74
Profitability Margins
Gross Profit Margin
15.15%13.33%14.76%18.50%12.16%
EBIT Margin
4.39%3.34%4.29%6.69%-5.40%
EBITDA Margin
8.20%7.16%8.75%10.93%-1.22%
Operating Profit Margin
4.39%3.34%4.55%8.54%-3.44%
Pretax Profit Margin
2.78%1.54%2.28%3.79%-6.87%
Net Profit Margin
1.20%0.64%1.19%0.77%-5.27%
Continuous Operations Profit Margin
2.36%1.33%2.08%2.59%-6.91%
Net Income Per EBT
43.11%41.63%52.17%20.30%76.67%
EBT Per EBIT
63.22%46.06%50.15%44.38%199.39%
Return on Assets (ROA)
1.21%0.68%1.12%0.80%-4.90%
Return on Equity (ROE)
3.78%2.15%3.43%2.47%-16.74%
Return on Capital Employed (ROCE)
7.02%5.46%6.60%12.93%-4.56%
Return on Invested Capital (ROIC)
4.43%3.48%4.53%7.08%-3.70%
Return on Tangible Assets
1.29%0.72%1.18%0.84%-5.15%
Earnings Yield
8.51%5.01%15.10%5.76%-45.62%
Efficiency Ratios
Receivables Turnover
6.83 7.91 7.81 7.96 5.70
Payables Turnover
7.23 9.21 6.61 7.63 7.14
Inventory Turnover
4.52 4.95 3.34 5.20 5.64
Fixed Asset Turnover
1.82 1.88 1.75 1.84 1.70
Asset Turnover
1.01 1.05 0.94 1.04 0.93
Working Capital Turnover Ratio
-83.35 51.89 21.66 20.14 13.36
Cash Conversion Cycle
83.72 80.26 100.63 68.15 77.60
Days of Sales Outstanding
53.43 46.17 46.71 45.83 64.02
Days of Inventory Outstanding
80.77 73.73 109.14 70.15 64.66
Days of Payables Outstanding
50.48 39.64 55.22 47.82 51.09
Operating Cycle
134.20 119.90 155.85 115.98 128.69
Cash Flow Ratios
Operating Cash Flow Per Share
6.17 5.54 6.71 11.64 1.29
Free Cash Flow Per Share
2.65 2.67 5.13 10.52 0.22
CapEx Per Share
3.52 2.87 1.57 1.12 1.07
Free Cash Flow to Operating Cash Flow
0.43 0.48 0.77 0.90 0.17
Dividend Paid and CapEx Coverage Ratio
1.16 1.18 2.05 10.38 0.85
Capital Expenditure Coverage Ratio
1.75 1.93 4.26 10.38 1.20
Operating Cash Flow Coverage Ratio
0.31 0.27 0.13 0.53 0.05
Operating Cash Flow to Sales Ratio
0.09 0.08 0.04 0.14 0.02
Free Cash Flow Yield
28.21%29.06%39.22%97.38%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.68 19.94 6.61 17.37 -2.19
Price-to-Sales (P/S) Ratio
0.14 0.13 0.08 0.13 0.12
Price-to-Book (P/B) Ratio
0.46 0.43 0.23 0.43 0.37
Price-to-Free Cash Flow (P/FCF) Ratio
3.54 3.44 2.55 1.03 39.89
Price-to-Operating Cash Flow Ratio
1.52 1.66 1.95 0.93 6.77
Price-to-Earnings Growth (PEG) Ratio
0.01 -0.26 0.03 -0.15 0.01
Price-to-Fair Value
0.46 0.43 0.23 0.43 0.37
Enterprise Value Multiple
5.04 5.48 4.11 3.38 -37.20
Enterprise Value
250.98M 255.38M 239.14M 271.50M 310.76M
EV to EBITDA
5.04 5.48 4.11 3.38 -37.20
EV to Sales
0.41 0.39 0.36 0.37 0.45
EV to Free Cash Flow
10.41 10.55 11.65 2.84 156.87
EV to Operating Cash Flow
4.48 5.07 8.91 2.57 26.62
Tangible Book Value Per Share
28.58 29.86 79.65 35.07 32.58
Shareholders’ Equity Per Share
20.47 21.32 57.56 25.17 23.71
Tax and Other Ratios
Effective Tax Rate
0.15 0.13 0.09 0.32 >-0.01
Revenue Per Share
66.86 71.75 166.02 80.79 75.37
Net Income Per Share
0.80 0.46 1.98 0.62 -3.97
Tax Burden
0.43 0.42 0.52 0.20 0.77
Interest Burden
0.63 0.46 0.53 0.57 1.27
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.07 0.07 0.01 0.01
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
6.15 5.79 1.94 5.55 -0.25
Currency in ILS